CD
RVMD icon

Chapin Davis’s Revolution Medicines RVMD Stock Holding History

Chapin Davis’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$246K Buy
+1,200
New +$238K 0.05% 212

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
LPPL
Loftus Peak Pty Ltd Sydney, Australia $781M AUM
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Wedmont Private Capital
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Chapin Davis's RVMD Position: Q3 2026 in Review

Chapin Davis opened a new position in Revolution Medicines (RVMD) in Q3 2026: 1,200 shares worth $246K. The stake represents 0.05% of the portfolio and ranks #212 among its holdings.

59 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Chapin Davis held 1,200 shares of Revolution Medicines worth $246K as of Q3 2026.
  • Revolution Medicines was a new Chapin Davis position in Q3 2026.
  • Revolution Medicines made up 0.05% of Chapin Davis's portfolio in Q3 2026, its #212 holding.
  • 59 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Chapin Davis's 13F filing for Q3 2026, filed 9 Oct 2026.